Trial Profile
Bariatric Surgery and Pharmacokinetics Irbesartan: BAR-MEDS Irbesartan
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Diabetic nephropathies; Hypertension; Obesity
- Focus Pharmacokinetics
- Acronyms BAR-MEDS Irbesartan
- 28 Mar 2018 New trial record